Forum Discussion
Two steps forward, one step back – news on access to CDKs in second line treatment
Hello everyone,
BCNA has an update on access to CDKs as
second line treatment. Pfizer have this week advised BCNA about a new capped access
program for the CDK inhibitor palbociclib (lbrance) wh...
Thankyou Marinne
Wonderful to know that some access progress has been achieved for longer term met patients.
All the best to everyone who are able to now afford and start
Bright in hope
Wonderful to know that some access progress has been achieved for longer term met patients.
All the best to everyone who are able to now afford and start
Bright in hope